MAP2K7 and pancreatic neoplasm: We have previously reported that FBP1 regulates the sensitivity of pancreatic cancer to various types of small molecules, including BET inhibitors, gemcitabine, MEK inhibitors, and AKT inhibitors [13, 14, 15].